MARKET WIRE NEWS

Outperform Recommendation Issued On ORIC By Oppenheimer

Source: KlickAnalytics

2026-02-24 01:15:04 ET

  • Oppenheimer analyst issues OUTPERFORM recommendation for ORIC on February 24, 2026 05:34AM ET.
  • The previous analyst recommendation was Outperform.
  • ORIC was trading at $11.71 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 10 - Buy recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations ...
    Full story available on KlickAnalytics.com
    Oric Pharmaceuticals Inc.

    NASDAQ: ORIC

    ORIC Trading

    -1.16% G/L:

    $11.623 Last:

    353,868 Volume:

    $11.96 Open:

    mwn-app Ad 300

    ORIC Latest News

    ORIC Stock Data

    $1,023,561,322
    83,384,701
    0.22%
    39
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    South San Francisco

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App